All Stories

  1. Instability of sputum molecular phenotypes in U-BIOPRED severe asthma
  2. Mitochondrial ROS and NLRP3 inflammasome in acute ozone-induced murine model of airway inflammation and bronchial hyperresponsiveness
  3. TRPV1 and TRPA1 in Lung Inflammation and Airway Hyperresponsiveness Induced by Fine Particulate Matter (PM2.5)
  4. Predicting Response to Triamcinolone in Severe Asthma by Machine Learning. Solving the Enigma
  5. Bromodomain and Extraterminal (BET) Protein Inhibition Restores Redox Balance and Inhibits Myofibroblast Activation
  6. “T2-high” in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin
  7. Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis
  8. Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline
  9. Personalised medicine in asthma: time for action
  10. Intracellular interactions of umeclidinium and vilanterol in human airway smooth muscle
  11. Clinical management of severe therapy-resistant asthma
  12. A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED
  13. T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED
  14. Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD
  15. Cytokine inhibition in the treatment of COPD
  16. Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD
  17. The investigation of severe asthma to define phenotypes